Spanish Biotech Database

TAIPEI, Taiwan, April 30, 2019 /PRNewswire/ -- Gilead Sciences, Inc. today announced that with effect from 1 May 2019, Vemlidy (tenofovir alafenamide, TAF) 25 mg, a once-daily treatment for chronic hepatitis B in adults with compensated liver disease will be made available to patients via the... Read more ››

By: PR Newswire Association LLC. - 30 Apr 2019

Novo Nordisk A/S - Share repurchase programme

By: Nasdaq / GlobenewsWire - 29 Apr 2019

Sanofi: FDA approves Praluent® (alirocumab) to prevent heart attack, stroke and unstable angina requiring hospitalization

By: Nasdaq / GlobenewsWire - 27 Apr 2019

ZynquistaTM now approved in the European Union for treatment of adults with type 1 diabetes

By: Nasdaq / GlobenewsWire - 26 Apr 2019

Novo Nordisk receives positive opinion from the European regulatory authorities for Esperoct® (turoctocog alfa pegol, N8-GP) for the treatment of haemophilia A

By: Nasdaq / GlobenewsWire - 26 Apr 2019

Sanofi delivers strong Q1 2019 business EPS growth of 9.4% at CER

By: Nasdaq / GlobenewsWire - 26 Apr 2019

Novo Nordisk files for EU regulatory approval of oral semaglutide for the treatment of type 2 diabetes

By: Nasdaq / GlobenewsWire - 26 Apr 2019

BD Launches Preventing Risks of Infections and Medication Errors in IV Therapy (PRIME) in Asia

SINGAPORE, April 26, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company), a leading global medical technology company, has launched a new patient safety program for hospitals, called Preventing Risks of Infections and Medication Errors in IV Therapy (PRIME). Aimed at addressing the... Read more ››

By: PR Newswire Association LLC. - 26 Apr 2019

« 1 2 3 4 5 6 7

Looking for companies outside of Spain?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

October 2019
- Rennes: NutrEvent
- San Francisco: BIO Investor Forum
- Melbourne: Biotech-Pharma Product and Company Valuation - introduction

See Events »

Add an Event »

Latest company news

Novo Nordisk A/S – Share repurchase programme
21 Oct 2019 (Nasdaq / GlobenewsWire)

Sanofi: information concerning the total number of voting rights and shares, September 2019
21 Oct 2019 (Nasdaq / GlobenewsWire)

Novo Nordisk A/S – Share repurchase programme
14 Oct 2019 (Nasdaq / GlobenewsWire)

News in the Life Sciences Industry

Novo Nordisk A/S: Share repurchase programme

Release date of three-month interim report 2019 for ALK and audio cast

B. Braun Signs U.S. Distribution Agreement with Nexus Medical, LLC for Its Nexus TKO®-6P Luer Activated Anti-Reflux Device

Novo Nordisk A/S - Total number of voting rights and share capital in Novo Nordisk A/S as of 30 April 2019

Sanofi: Annual General Meeting of April 30, 2019

Immucor Announces Health Canada Approval for NEO Iris™; Next Generation, Fully Automated Instrument for Transfusion Medicine

Taiwan National Health Insurance Administration of the Ministry of Health and Welfare Approves Vemlidy(R) (tenofovir alafenamide) for Reimbursement

Novo Nordisk A/S - Share repurchase programme

Sanofi: FDA approves Praluent® (alirocumab) to prevent heart attack, stroke and unstable angina requiring hospitalization

ZynquistaTM now approved in the European Union for treatment of adults with type 1 diabetes

Novo Nordisk receives positive opinion from the European regulatory authorities for Esperoct® (turoctocog alfa pegol, N8-GP) for the treatment of haemophilia A

Sanofi delivers strong Q1 2019 business EPS growth of 9.4% at CER

Novo Nordisk files for EU regulatory approval of oral semaglutide for the treatment of type 2 diabetes

BD Launches Preventing Risks of Infections and Medication Errors in IV Therapy (PRIME) in Asia

B. Braun launches the First FDA-Approved Heparin Sodium Prefilled Syringe with attached safety needle

Novo Nordisk A/S - Reduction of the share capital

Novo Nordisk A/S: Articles of Association for Novo Nordisk A/S

Looking for companies outside of Spain?

Partners

Upcoming Life Sciences Events

Latest company news